Drugs based on immune factors - a class that includes cytokines, lymphocyte receptors, signaling enzymes, antibodies and transcription factors - have demonstrated the capability to effectively treat a host of diseases that had previously been considered to be intractable.........more

While the ability of recombinant protein drugs to treat previously refractory conditions continues to generate excitement and investment, the complex structure of these therapeutic substances require special formulation and delivery strategies, creating special challenges for drug developers and their formulation technol ........more

Within the injectable segment, the sands are shifting as several factors converge to drive demand for delivery methods that increase safety, compliance and ease-of-use. While the economics of traditional disposable syringe devices remain compelling, a number of companies are combining synthetic materials .....more